Share the Science: Regenerative Stem Cell Therapies for the Wounded Warrior - Dr. Lloyd Rose10/8/2020
Save the Cord Foundation and WellSky are proud to welcome Dr. Lloyd Rose of US Army Medical Material Development Activity, as our featured speaker for our next edition of Share the Science on October 22nd, 2020. Join us to hear Dr. Rose present his research regarding regenerative stem cell therapies and how the US Department of Defense is harnessing this research to help injured soldiers. Recording now available . Click here to view. Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field. As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here. Department of Defense Harnessing Stem Cell TherapiesThe last two decades have seen great improvement in our ability to keep traumatically injured soldiers alive from wounds that previously would have proven fatal. However, the result has been an increase in severe functional deficits due to loss of tissue and limbs. Harnessing stem cell therapies to regenerate lost or damaged tissue holds out hope for restoring our Wounded Warriors to full functionality and improving their quality of life.
Register now to discover some of the extraordinary work the DoD is doing in cell therapy and regenerative medicine to address traumatic injuries, especially those suffered by Military personnel. SHARE THE SCIENCE with Lloyd Rose, PhD Regenerative Medicine Portfolio Manager, Clinical and Rehabilitative Medicine Research Program US Army Medical Material Development Activity "Stem Cell Therapies for the Wounded Warrior" Free webinar. Open to the public. Thursday, October 22nd - 2pm Eastern Time/ 11am Pacific Time CLICK HERE TO WATCH THE RECORDING About the speaker
We wish to thank Dr. Lloyd Rose for volunteering his time to speak on
Share the Science and sharing his valuable insight on regenerative stem cell therapies for injured soldiers. We also wish to also thank our generous sponsor and partner for this event, WellSky Health, who continue to support cord blood education through our “Share the Science” series. Save the Cord Foundation and WellSky are proud to welcome Sairah Ahmed, M.D. from the University of Texas - MD Anderson Cancer Center, as our featured speaker for our next edition of Share the Science on September 24th, 2020. Join us to hear Dr. Ahmed present her research regarding CAR-T Cell therapy and the multiple constructs of CAR-T therapy, and when they are effective for the treatment of certain types of lymphoma. RECORDING NOW AVAILABLE: VIEW IT HERE. Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field. As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here. Latest Research: CAR-T Cell Therapy for LymphomaWe are thrilled to welcome Dr. Sairah Ahmed as our next featured speaker on Share the Science. We have had many requests from the Save the Cord community to highlight the latest research in CAR-T cell therapy and as it relates to cord blood. Indeed, this is a new and emerging area of scientific research with great promise. Given that we welcome not only healthcare professionals to our webinars but also the general public, we feel it is important to give you a brief overview of the basics regarding CAR-T cell therapy.
In this special webinar focused on CAR-T Cell Therapy, Dr. Ahmed will discuss how cord blood sources play a critical role in treating select lymphomas including the potential of using CAR-T cell therapy. This method of treatment shows particular promise in treating lymphomas that are not responding to other methods. During Dr. Ahmed's presentation she will highlight which patients are the best candidates for treatment with CAR-T therapy and how is CAR-T therapy different from autologous transplant for lymphoma. She will also discuss which types of lymphoma can be treated with CAR-T therapy. The toxicity specific to CAR-T therapy, as well as novel lymphoma cellular therapy treatment from cord blood sources will also be discussed. SHARE THE SCIENCE with Sairah Ahmed, M.D. Associate Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine The University of Texas MD Anderson Cancer Center, Houston, TX "Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Lymphoma" Free webinar. Open to the public. Thursday, September 24th - 2pm Eastern Time/ 11am Pacific Time RECORDING NOW AVAILABLE About the speakerWe wish to thank Dr. Sairah Ahmed for volunteering her time to speak on
Share the Science and sharing her valuable insight on CAR-T Cell Therapies using cord blood. We also wish to also thank our generous sponsor and partner for this event, WellSky Health, who continue to support cord blood education through our “Share the Science” series. Save the Cord Foundation and WellSky are proud to welcome Jaap Jan Boelens, MD, PhD from Memorial Sloan Kettering Cancer Center, as our featured speaker for our next edition of Share the Science on August 20th, 2020. Join us to hear Dr. Boelens present his research on cord blood transplants and the numerous factors influencing hematopoietic cell transplantation (HCT) outcomes. Recording now available, see below. Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field. As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here. Understanding the nuances of cord blood transplantation, pre- and post-transplant, are key to treating any patient undergoing this procedure. Often the patient's survival and quality of life post-transplant is driven by their body's ability to rebuild the immune system. Join us on August 20th to learn how transplant doctors can exploit cord blood's unique qualities during this process of recovery and period of reconstitution. Dr. Jaap Boelens will present his latest research in this area and explain how reconstituting immune cells from cord blood differs from other stem cell sources. Many factors influence HCT outcomes, such as the selected graft source, type of infused cell subsets, cell doses, and the protocols used for conditioning, immune suppression, and treatment of adverse events. Recent pharmacokinetic studies show that compounds used in the conditioning regimen (e.g. busulphan, fludarabine, anti-thymocyte globulin) should use patient-specific dosing to achieve optimal exposure in every individual patient. Attendees of this Share the Science webinar will learn:
SHARE THE SCIENCE with Jaap Jan Boelens, MD, PhD Chief, Stem Cell Transplantation and Cellular Therapies Memorial Sloan Kettering Cancer Center "Immune Reconstitution after Cord Blood Transplantation" Free webinar. Open to the public. Thursday, August 20th - 12 noon Eastern Time/ 9am Pacific Time RECORDING NOW AVAILABLE About the speaker
We wish to thank Dr. Jaap Jan Boelens for volunteering his time to speak on
Share the Science and sharing his valuable insight on immune reconstitution after cord blood transplantation. We also wish to also thank our generous sponsor and partner for this event, WellSky Health, who continue to support cord blood education through our “Share the Science” series. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2020
Categories |